Search the Newsreel

(PLSE) Risk Channels and Responsive Allocation

This article provides an in-depth AI-driven analysis for Pulse Biosciences Inc (NASDAQ: PLSE), highlighting strong sentiment across all horizons and compelling upside potential. It details institutional trading strategies with specific entry zones, targets, and stop losses for position trading, momentum breakout, and risk hedging. …

Will Telstra’s Higher FY26 Dividend and Solid Earnings Shift Telstra Group's (ASX:TLS) Narrative?

USA Financial Formulas Acquires New Position in Regeneron Pharmaceuticals, Inc. $REGN

USA Financial Formulas has acquired a new stake in Regeneron Pharmaceuticals (NASDAQ:REGN), purchasing 1,457 shares valued at approximately $1.13 million, making it their 27th-largest portfolio holding. Institutional investors collectively own 83.31% of Regeneron, with several major firms significantly increasing their positions. The company recently …

Oppenheimer Asset Management Inc. Buys New Position in CSW Industrials, Inc. $CSW

Oppenheimer Asset Management Inc. has acquired a new position of 14,518 shares in CSW Industrials, Inc. (NYSE:CSW), valued at approximately $4.04 million. CSW Industrials recently reported strong quarterly earnings, beating analyst estimates with an EPS of $3.84 and a 33% year-over-year revenue increase. The …

Price to earnings forward of EIH Associated Hotels Limited – NSE:EIHAHOTELS

AMAT Q2 Deep Dive: AI Demand and Advanced Packaging Drive Guidance Upside, Market Reacts Cautiously

AMAT Q2 Deep Dive: AI Demand and Advanced Packaging Drive Guidance Upside, Market Reacts Cautiously Semiconductor machinery manufacturer Applied Materials (NASDAQ:AMAT) announced better-than-expected revenue in Q2 CY2026, with sales up 24.8% year on year to $9.12 billion. On top of that, next quarter's revenue …

River Road Asset Management LLC Cuts Stake in Wells Fargo & Company $WFC

River Road Asset Management LLC has reduced its stake in Wells Fargo & Company (WFC) by 2.3% in the second quarter, now holding 693,210 shares valued at $57.3 million. Despite this reduction, institutional investors collectively own 75.9% of WFC, and the company reported stronger-than-expected …

Mission Wealth Management LP Acquires 17,301 Shares of Wells Fargo & Company $WFC

Mission Wealth Management LP increased its stake in Wells Fargo & Company by 20.2%, acquiring an additional 17,301 shares, bringing its total to 102,870 shares valued at approximately $8.5 million. Other institutional investors also modified their holdings, contributing to institutional ownership of 75.9%. Wells …

OFI Invest Asset Management Has $17.70 Million Stake in Wells Fargo & Company $WFC

GSA Capital Partners LLP Purchases New Shares in Commercial Metals Company $CMC

GSA Capital Partners LLP has acquired a new stake of 33,406 shares in Commercial Metals Company (NYSE:CMC), valued at approximately $2.096 million. Other institutional investors have also adjusted their positions, and insider activity shows the CEO and a director purchasing shares. The company recently …

13,576 Shares in Eagle Materials Inc $EXP Bought by GSA Capital Partners LLP

GSA Capital Partners LLP recently acquired a new stake of 13,576 shares in Eagle Materials Inc (NYSE:EXP), valued at approximately $3.055 million, during the second quarter. Other institutional investors also adjusted their holdings in the company, with notable increases from EverSource Wealth Advisors LLC, …

Focus Partners Advisor Solutions LLC Makes New Investment in General Mills, Inc. $GIS

Focus Partners Advisor Solutions LLC has made a new investment in General Mills, Inc. (NYSE:GIS), purchasing 71,557 shares valued at approximately $2.49 million during the second quarter. This move is part of broader institutional interest, with several other major firms like State Street Corp …

DO & CO Aktiengesellschaft (VIE:DOC) hat soeben die Ergebnisse des ersten Quartals veröffentlicht: Das prognostizieren Analysten für dieses Jahr

Aberdeen Group plc Trims Stock Holdings in Johnson Controls International plc $JCI

Aberdeen Group plc reduced its stake in Johnson Controls International plc (NYSE:JCI) by 3.4% during the second quarter, now holding 970,980 shares valued at $141.87 million. Other institutional investors also adjusted their holdings, with 90.05% of the stock owned by hedge funds and institutional …

Is Ionis Pharmaceuticals (IONS) Undervalued Following Its Pullback?

Commonwealth Retirement Investments LLC Reduces Holdings in Applied Materials, Inc. $AMAT

Ionis (IONS) Stock Looks Like A Bargain On Value But Full On Sales

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Ionis Pharmaceuticals stock carries a strong three year return record alongside a high overall value score, yet current market multiples still point to the shares …

Citizens & Northern Corp Takes Position in Wells Fargo & Company $WFC

Fort Washington Investment Advisors Inc. OH Increases Stock Position in Wells Fargo & Company $WFC

Die secunet Security Networks Aktiengesellschaft (ETR:YSN) hat soeben ihre Halbjahresergebnisse veröffentlicht, und Analysten passen ihre Prognosen an.

Asio Capital LLC Sells 13,278 Shares of Wells Fargo & Company $WFC

Asio Capital LLC reduced its stake in Wells Fargo & Company by 23.7% in Q2, selling 13,278 shares but still holding 42,740 shares worth $3.53 million. This comes as Wells Fargo reported strong quarterly earnings, with EPS of $1.96 and revenue of $22.62 billion, …

Eagle Materials Inc (NYSE:EXP) Given Average Rating of "Hold" by Brokerages

Eagle Materials Inc. (NYSE:EXP) has received an average "Hold" rating from ten brokerages, with nine analysts recommending a hold and one a buy. The average 12-month price target is $222.56, slightly above its current share price of $208.35. The company's recent quarterly earnings missed …

Phathom Pharmaceuticals (PHAT) Stock Sees Modest Fair Value Cut After Analyst Target Cuts

Phathom Pharmaceuticals (PHAT) has experienced a modest fair value cut from US$23.70 to US$21.50 following analyst target revisions. This adjustment is due to updated Q2 results, revised 2026 revenue guidance, and new perspectives on their drug Voquezna's commercial path. While some firms remain bullish …

Sinclairs Hotels Ltd posts a total income of INR 6512.59 lakh for the year ended March 31, 2024

Applied Digital Corporation (NASDAQ:APLD) Receives Average Recommendation of "Moderate Buy" from Brokerages

Applied Digital Corporation (NASDAQ:APLD) has received an average "Moderate Buy" recommendation from brokerages, with an average 12-month price target of $68.15. Despite a significant year-over-year revenue increase of 406.3%, the company missed EPS estimates, reporting a loss of $0.39 against an expected loss of …

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Consensus Rating of "Moderate Buy" by Brokerages

Tarsus Pharmaceuticals (NASDAQ:TARS) has received a "Moderate Buy" consensus rating from brokerages, with an average 12-month price target of $90.50, significantly higher than its current share price of $69.20. The company recently reported quarterly revenue of $173.91 million, surpassing estimates, but its loss per …

Huntington Ingalls Industries, Inc. (NYSE:HII) Receives Average Rating of "Moderate Buy" from Analysts

Huntington Ingalls Industries (NYSE:HII) has received a "Moderate Buy" rating from analysts, with an average 12-month price target of $378.88. The company recently reported strong quarterly earnings of $5.27 per share, significantly beating estimates, and revenue increased by 10.9% year over year. Despite recent …

Citius Pharmaceuticals Reports LYMPHIR Revenue Growth, Explores CAR-T Combination

Citius Pharmaceuticals reported promising early results for its approved drug LYMPHIR in new indications, including an 86% objective response rate in a Phase 1 CAR-T combination trial for diffuse large B-cell lymphoma and a 24% ORR in gynecologic malignancies. The company also announced strong …

Pulse Biosciences (PLSE) Prices A $75 Million Offering, Is The Stock Fully Valued?

Pulse Biosciences (PLSE) recently announced a $75 million at-the-market equity offering and reported wider second-quarter losses, impacting existing shareholders. Despite strong recent share price performance, with a 30-day return of 55.30% and a year-to-date return of 232.64%, the stock now trades above the latest …

MBPFY (Mitchells & Butlers) Enterprise Value : $4,050 Mil (As of Aug. 16, 2026) ***

Will Mirum Pharmaceuticals' (MIRM) Widening Net Losses Test Its Growth-Focused Investment Narrative?

Mirum Pharmaceuticals reported a significant net loss for Q2 and H1 2026, with basic loss per share rising, which highlights increased costs relative to revenue. This widening loss intensifies focus on cash burn and funding risks, despite upcoming clinical and regulatory catalysts such as …

Wall Street Zen Downgrades Mirum Pharmaceuticals (NASDAQ:MIRM) to Sell

Wall Street Zen has downgraded Mirum Pharmaceuticals (NASDAQ:MIRM) from "hold" to "sell," despite the company reporting better-than-expected quarterly revenue of $176.24 million, a 37.9% increase year-over-year. The downgrade comes as the company missed earnings per share estimates, reporting a loss of $1.06 against a …

Responsive Playbooks and the ETON Inflection

This article provides an AI-driven analysis for Eton Pharmaceuticals Inc. (NASDAQ: ETON), highlighting weak near and mid-term sentiment but a positive long-term outlook. It details specific trading strategies including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis. The report suggests …

Solstice Advanced Materials, Inc. (SOLS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Solstice Advanced Materials, Inc. (NASDAQ: SOLS) following a significant stock price drop after its announcement to acquire Element Solutions for $14.5 billion. Despite the CEO's positive outlook on the acquisition, …

Dorchester Minerals (DMLP) Could Be 74% Below Fair Value As Earnings Improve

Rigel Pharmaceuticals (RIGL) Stock Sees Fair Value Lift As Veppanu Launch Adds Growth Hope

Rigel Pharmaceuticals (RIGL) has seen its fair value estimate increase from US$51.6 to US$61.2 per share, primarily due to the launch of Veppanu in the U.S. and the international potential of Rezlidhia through a partnership with Kissei. Analysts, such as H.C. Wainwright, view Veppanu …